|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 24910 |
FusionGeneSummary for NSD1_PCDHB15 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: NSD1_PCDHB15 | Fusion gene ID: 24910 | Hgene | Tgene | Gene symbol | NSD1 | PCDHB15 | Gene ID | 64324 | 56121 |
| Gene name | nuclear receptor binding SET domain protein 1 | protocadherin beta 15 | |
| Synonyms | ARA267|KMT3B|SOTOS|SOTOS1|STO | PCDH-BETA15 | |
| Cytomap | 5q35.3 | 5q31.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specificH3-K36-HMTaseH4-K20-HMTaseNR-binding SET domain-containing proteinandrogen receptor coactivator 267 kDa proteinandrogen receptor-associated coregulator 267androgen receptor-as | protocadherin beta-15 | |
| Modification date | 20180519 | 20180523 | |
| UniProtAcc | Q96L73 | Q9Y5E8 | |
| Ensembl transtripts involved in fusion gene | ENST00000354179, ENST00000439151, ENST00000347982, ENST00000361032, ENST00000511258, | ENST00000231173, | |
| Fusion gene scores | * DoF score | 17 X 10 X 13=2210 | 1 X 1 X 1=1 |
| # samples | 20 | 1 | |
| ** MAII score | log2(20/2210*10)=-3.46597446450407 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(1/1*10)=3.32192809488736 | |
| Context | PubMed: NSD1 [Title/Abstract] AND PCDHB15 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | NSD1 | GO:0045893 | positive regulation of transcription, DNA-templated | 11509567 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | OV | TCGA-23-1122-01A | NSD1 | chr5 | 176666866 | + | PCDHB15 | chr5 | 140625051 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000354179 | ENST00000231173 | NSD1 | chr5 | 176666866 | + | PCDHB15 | chr5 | 140625051 | + |
| 5CDS-intron | ENST00000439151 | ENST00000231173 | NSD1 | chr5 | 176666866 | + | PCDHB15 | chr5 | 140625051 | + |
| 5CDS-intron | ENST00000347982 | ENST00000231173 | NSD1 | chr5 | 176666866 | + | PCDHB15 | chr5 | 140625051 | + |
| 5CDS-intron | ENST00000361032 | ENST00000231173 | NSD1 | chr5 | 176666866 | + | PCDHB15 | chr5 | 140625051 | + |
| intron-intron | ENST00000511258 | ENST00000231173 | NSD1 | chr5 | 176666866 | + | PCDHB15 | chr5 | 140625051 | + |
Top |
FusionProtFeatures for NSD1_PCDHB15 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| NSD1 | PCDHB15 |
| Histone methyltransferase. Preferentially methylates'Lys-36' of histone H3 and 'Lys-20' of histone H4 (in vitro).Transcriptional intermediary factor capable of both negatively orpositively influencing transcription, depending on the cellularcontext. {ECO:0000269|PubMed:21196496}. | Potential calcium-dependent cell-adhesion protein. Maybe involved in the establishment and maintenance of specificneuronal connections in the brain. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for NSD1_PCDHB15 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for NSD1_PCDHB15 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| NSD1 | ZNF496, AR, RELA, AFF1, SIRT7, HIST4H4, TNFRSF21, RARA, RXRA, ESR1, PPARG, VDR, THRB, RORA, RORB, HNF4G, NR2F6, ESRRA, NR5A2, NR6A1, NR2F1, NR2F2, NR2E1, HIST3H3, HIST1H1B, ATRX, SNORD3A, HIST1H1D, HIST1H1C, GAR1, HIST1H3A, HIST1H4A, POLR2A, ZFY, ZBTB48, ZNF692, MECP2, TRIM25 | PCDHB15 | BLMH, AP3S1, NAP1L1, NRD1, SOAT1, SSR3, ADNP, PRDX5, HIGD1A, GPATCH4, CEP192, PLXNA3, ENY2, TOMM22, SLC25A19, RNF123, MRPS25, CRTC3, DERL1, ARHGAP39, DPY30, TBCK, C5orf24, NANP, HLA-A |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for NSD1_PCDHB15 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for NSD1_PCDHB15 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | NSD1 | C0175695 | Sotos' syndrome | 14 | CTD_human;ORPHANET;UNIPROT |
| Hgene | NSD1 | C0004352 | Autistic Disorder | 1 | CTD_human |
| Hgene | NSD1 | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
| Hgene | NSD1 | C0265210 | Weaver syndrome | 1 | CTD_human;ORPHANET |
| Hgene | NSD1 | C3714756 | Intellectual Disability | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|